dc.description.abstract |
<p>Even though women make up over half the population in the United States, medical
advancements in areas of women's health have typically lagged behind the rest of the
medical field. Specifically, two major threats to women's reproductive health include
human immunodeficiency virus (HIV), and cervical cancer with accompanying human papillomavirus
(HPV) infection. This dissertation presents the development and application of two
novel optical imaging technologies aimed at improving these aspects of women's reproductive
health.</p><p>The presented work details the instrumentation development of a probe-based,
dual-modality optical imaging instrument, which uses simultaneous imaging of fluorimetry
and multiplexed low coherence interferometry (mLCI) to measure in vivo microbicide
gel thickness distributions. The study explores the optical performance of the device
and provides proof of concept measurements on a calibration socket, tissue phantom,
and in vivo human data. Once the instrument is fully characterized, it is applied
in a clinical trial in which in vivo human vaginal gel thickness distributions. The
gel distribution data obtained by the modalities are compared in order to assess the
ability of mLCI making accurate in vivo measurements. Differences between the fluorimetry
and mLCI modalities are then exploited in order to show a methodology for calculating
the extent of microbicide gel dilution with the dual-modality instrument data.</p><p>Limitations
in cervical cancer screening are then addressed as angle-resolved low coherence interferometry
(a/LCI) is used in an ex vivo pilot study to assess the feasibility of a/LCI in identifying
dysplasia in cervical tissues. The study found that the average nuclear diameter
found by a/LCI in the basal layer of ectocervical epithelium showed a statistically
significant increase in size in dysplastic tissue. These results indicate that a/LCI
is capable of identifying cervical dysplasia in ectocervical epithelium. The results
of the work presented in this dissertation show that dual-modality optical imaging
with fluorimetry and mLCI, and the a/LCI technique show promise in advancing technologies
that are used in the field of women's reproductive health.</p>
|
|